Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Potential Biomarkers and Therapeutic Targets for Periodontitis. | Int Dent J | 2025 | 39532570 | PubTator, text mining | PubMed |
| Molecular and Clinical Profiles of Pediatric Monogenic Diabetes Subtypes: Comprehensive Genetic Analysis of 138 Patients. | J Clin Endocrinol Metab | 2025 | 39504571 | PubTator, text mining | PubMed |
| Unraveling the genetic basis of MODY: insights from next-generation sequencing. | J Appl Genet | 2025 | 39361122 | PubTator, text mining | PubMed |
| Advances in reversible covalent kinase inhibitors. | Med Res Rev | 2025 | 39287197 | PubTator, text mining | PubMed |
| SLAM/SAP signaling regulates discrete γδ T cell developmental checkpoints and shapes the innate-like γδ TCR repertoire. | Elife | 2024 | 39656519 | PubTator, text mining | PubMed |
| ELF1 serves as a potential biomarker for the disease activity and renal involvement in systemic lupus erythematosus. | Sci Rep | 2024 | 39496744 | PubTator, text mining | PubMed |
| Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus. | Mol Immunol | 2024 | 39476438 | PubTator, text mining | PubMed |
| Association of BLK and BANK1 gene polymorphisms with systemic lupus erythematous in Egyptian patients. | Egypt J Immunol | 2024 | 39417739 | PubTator, text mining | PubMed |
| Co-inheritance of Rare Variants of Maturity-Onset Diabetes of the Young (MODY): A Case Report and Review of the Literature. | Cureus | 2024 | 39391454 | PubTator, text mining | PubMed |
| Whole exome sequencing in patients with childhood-onset systemic lupus erythematosus: Results from a Croatian national study. | Scand J Immunol | 2024 | 39380326 | PubTator, text mining | PubMed |
| Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke. | J Am Heart Assoc | 2024 | 39119979 | PubTator, text mining | PubMed |
| Discovery of new myositis genetic associations through leveraging other immune-mediated diseases. | HGG Adv | 2024 | 39044428 | PubTator, text mining | PubMed |
| Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. | Clin Rheumatol | 2024 | 38997544 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome. | Arthritis Rheumatol | 2024 | 38973605 | PubTator, text mining | PubMed |
| Causal links between gut microbiomes, cytokines and risk of different subtypes of epilepsy: a Mendelian randomization study. | Front Neurosci | 2024 | 38855442 | PubTator, text mining | PubMed |
| Altered Expression of B Cell Receptor Signaling Pathway Genes in Peripheral Blood of Patients with Multiple Sclerosis. | Iran J Allergy Asthma Immunol | 2024 | 38822513 | PubTator, text mining | PubMed |
| Exon-junction complex association with stalled ribosomes and slow translation-independent disassembly. | Nat Commun | 2024 | 38760352 | PubTator, text mining | PubMed |
| Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. | Pharmacol Rep | 2024 | 38739359 | PubTator, text mining | PubMed |
| The BulkECexplorer compiles endothelial bulk transcriptomes to predict functional versus leaky transcription. | Nat Cardiovasc Res | 2024 | 38708406 | PubTator, text mining | PubMed |
| Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy. | Cancer Lett | 2024 | 38408603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=5